Form 8-K - Current report:
SEC Accession No. 0001213900-21-031157
Filing Date
2021-06-07
Accepted
2021-06-07 09:15:37
Documents
3
Period of Report
2021-06-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea142288-8k_citiuspharma.htm 8-K 32189
2 PRESS RELEASE DATED JUNE 7, 2021 ea142288ex99-1_citiuspharma.htm EX-99.1 14408
3 GRAPHIC ex99-1_01.jpg GRAPHIC 13748
  Complete submission text file 0001213900-21-031157.txt   66958
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 21998429
SIC: 2834 Pharmaceutical Preparations